{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:12:55Z","timestamp":1784074375238,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0579"],"award-info":[{"award-number":["W81XWH-22-1-0579"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cllc.2025.07.010","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:56:54Z","timestamp":1753977414000},"page":"e609-e615.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Rebecca A.","family":"Deek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Langenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kontopidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Hathout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Onal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Missak","family":"Haigentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma K.","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Deek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cllc.2025.07.010_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2025.07.010_bib0002","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/PPO.0000000000000432","article-title":"Oligometastatic and oligoprogression disease and local therapies in prostate cancer","volume":"26","author":"Deek","year":"2020","journal-title":"Cancer J"},{"issue":"29","key":"10.1016\/j.cllc.2025.07.010_bib0003","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.22.00644","article-title":"Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer: analysis of STOMP and ORIOLE trials","volume":"40","author":"Deek","year":"2022","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cllc.2025.07.010_bib0004","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.cllc.2025.07.010_bib0005","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2025.07.010_bib0006","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.cllc.2025.07.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2025.07.010_bib0008","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10185","key":"10.1016\/j.cllc.2025.07.010_bib0009","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.cllc.2025.07.010_bib0010","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2025.07.010_bib0011","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs. stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2025.07.010_bib0012","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.eururo.2020.12.040","article-title":"The mutational landscape of metastatic castration-sensitive prostate cancer: The spectrum theory revisited","volume":"80","author":"Deek","year":"2021","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.cllc.2025.07.010_bib0013","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41391-021-00484-4","article-title":"Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomics","volume":"25","author":"Sutera","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.cllc.2025.07.010_bib0014","doi-asserted-by":"crossref","first-page":"423","DOI":"10.12688\/f1000research.52546.3","article-title":"Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studies","volume":"10","author":"Petrelli","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.cllc.2025.07.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2023.04.025","article-title":"Clinical and genomic differences between advanced molecular imaging-detected and conventional imaging-detected metachronous oligometastatic castration-sensitive prostate cancer","author":"Sutera","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.cllc.2025.07.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001792","article-title":"LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types","volume":"9","author":"Brown","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.cllc.2025.07.010_bib0017","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fimmu.2019.01113","article-title":"Association of LRP1B mutation with tumor mutation burden and outcomes in melanoma and non-small cell lung cancer patients treated with immune check-point blockades","volume":"10","author":"Chen","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.cllc.2025.07.010_bib0018","article-title":"Co-mutation of FAT3 and LRP1B in lung adenocarcinoma defines a unique subset correlated with the efficacy of immunotherapy","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.cllc.2025.07.010_bib0019","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.neo.2021.10.001","article-title":"Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing","volume":"23","author":"Li","year":"2021","journal-title":"Neoplasia"},{"issue":"12","key":"10.1016\/j.cllc.2025.07.010_bib0020","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/carcin\/bgab104","article-title":"Functional assessment of somatic STK11 variants identified in primary human non-small cell lung cancers","volume":"42","author":"Donnelly","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2025.07.010_bib0021","article-title":"Benchmarking outcomes for molecularly characterized synchronous oligometastatic non-small-cell lung cancer reveals EGFR mutations to Be associated with longer overall survival","volume":"7","author":"De","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2025.07.010_bib0022","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/0008-5472.CAN-13-1641","article-title":"VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation","volume":"74","author":"Fantozzi","year":"2014","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.cllc.2025.07.010_bib0023","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.cllc.2025.07.010_bib0024","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res"},{"issue":"6","key":"10.1016\/j.cllc.2025.07.010_bib0025","article-title":"HIF-1alpha promotes epithelial-mesenchymal transition and metastasis through direct regulation of ZEB1 in colorectal cancer","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2025.07.010_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730425001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:03:50Z","timestamp":1778943830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730425001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1525730425001536"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2025.07.010","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Genomic Features and Prognostic Biomarkers of Oligometastatic Nonsmall Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2025.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}